Jazz Pharmaceuticals JAZZ Professional Service Fees Payable
Professional Service Fees Payable at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's professional service fees payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's professional service fees payable?
- Jazz Pharmaceuticals (JAZZ) reported professional service fees payable of $22.2M in Q1 2026.
- How has Jazz Pharmaceuticals's professional service fees payable changed year-over-year?
- Jazz Pharmaceuticals's professional service fees payable decreased by 31.2% year-over-year, from $32.28M to $22.2M.
- What is the long-term trend for Jazz Pharmaceuticals's professional service fees payable?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's professional service fees payable has grown at a 28.1% compound annual growth rate (CAGR), from $6.66M to $23M.